Risk Factor Burden and Long‐Term Prognosis of Patients With Premature Coronary Artery Disease
Michel Zeitouni(Sorbonne Université), W. Schuyler Jones(Duke University), Svati H. Shah(Duke University), Jawan Abdulrahim(Duke Medical Center), Robert M. Clare(Duke University), Matthew T. Roe(Clinical Research Institute), Nishant Shah(Clinical Research Institute), Karen Chiswell(Amyloidosis Foundation), Neha J. Pagidipati(Duke University), Manesh R. Patel(Duke University)
Cited by 159
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
|Circulation|2020|9.4k
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
|Circulation|2019|9.1k
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
Heart Disease and Stroke Statistics—2021 Update
|Circulation|2021|5.7k